We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
+46.03%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$218M
AUM Growth
+$84.5M
Cap. Flow
+$76.9M
Cap. Flow %
35.29%
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
–
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
TECX
Tectonic Therapeutic
TECX
+$82.2M
2
ETRM
EnteroMedics Inc.
ETRM
+$346K

Top Sells

Rank Stock Value
1
RSLS
ReShape Lifesciences Inc. Common Stock
RSLS
+$3.26M
2
OCUL icon
Ocular Therapeutix
OCUL
+$2.47M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TECX
1
Tectonic Therapeutic
TECX
$717M
$78.1M 35.88%
+228,002
New +$82.2M
DCPH
2
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$67.5M 31.01%
1,716,303
– –
ASXC
3
DELISTED
Asensus Surgical, Inc.
ASXC
$32.9M 15.11%
580,515
– –
KALV
4
DELISTED
KalVista Pharmaceuticals
KALV
$20.9M 9.62%
2,579,490
– –
OCUL icon
5
Ocular Therapeutix
OCUL
$2.38B
$8.41M 3.86%
1,245,270
-359,937
-22% -$2.47M
XFOR icon
6
X4 Pharmaceuticals
XFOR
$419M
$6.79M 3.12%
10,383
– –
ATXS
7
DELISTED
Astria Therapeutics
ATXS
$2.74M 1.26%
47,628
– –
ETRM
8
DELISTED
EnteroMedics Inc.
ETRM
$346K 0.16%
+150,064
New +$346K
RSLS
9
DELISTED
ReShape Lifesciences Inc. Common Stock
RSLS
– –
-1,072
Closed -$3.26M

Similar funds

SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return

SV Health Investors's Q2 2018 Portfolio in Review

As of Q2 2018, SV Health Investors held 9 positions worth $218M, up 63% from $133M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SV Health Investors deployed $76.9M of net new capital in Q2 2018, opening 2 new positions. Its largest new stake was Tectonic Therapeutic: 228,002 shares worth $78.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Ocular Therapeutix, an estimated $2.47M trimmed.

  • SV Health Investors's largest Q2 2018 buy was Tectonic Therapeutic: 228,002 shares worth $78.1M.
  • SV Health Investors's biggest Q2 2018 reduction was Ocular Therapeutix, cutting an estimated $2.47M.
  • SV Health Investors fully exited ReShape Lifesciences Inc. Common Stock in Q2 2018, selling an estimated $3.26M.
  • SV Health Investors's ten largest holdings make up 100% of its $218M portfolio in Q2 2018.
  • SV Health Investors opened 2 new positions and closed 1 in Q2 2018.
  • SV Health Investors's portfolio value rose 63% quarter-over-quarter to $218M.

Based on SV Health Investors's 13F filing for Q2 2018, filed 6 Aug 2018.